NCT00739414View on ClinicalTrials.gov

Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2009

Conditions
CancerAdvanced Solid Tumor
Interventions
DRUG

LBH589

10, 15, 20 mg/m2, i.v. on day 1 and 8 of each 21 day cycle

Trial Locations (3)

Unknown

Novartis Investigational Site, Aichi Prefecture

Novartis Investigational Site, Hokkaido

Novartis Investigational Site, Hyogo Prefecture

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY